japan

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 47/100

   Clinical genetics and genetic counseling in the era of disease-modifying therapies for dementia: lessons from Japan

   ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of human genetics · 2026-11-04 · Treatments

   Recent advances in hereditary dementia research have clarified its molecular pathogenesis and clinical applications, with several advances already reaching implementation.

   • Treatments
   • Genetics
   • Side Effects
2. 57/100

   Interim analysis of all-case post-marketing surveillance study in Japan: lecanemab in patients with early Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 57 out of 100. The journal of prevention of Alzheimer's disease · 2026-03-17 · Treatments

   This interim analysis represents one of the largest real-world lecanemab cohorts reported globally to date.

   • Treatments
   • Side Effects
   • Genetics
3. 48/100

   Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Biomedicines · 2024-08-16 · Treatments

   1.5T MRI was the most common magnetic field strength, remaining stable from FY2015 to FY2021. 3.0T MRI usage slightly increased, although the COVID-19 pandemic in FY2020 led to a maximum reduction of 5%.

   • Treatments
   • Brain Scans
4. 38/100

   COVID-19 in older adults: Retrospective cohort study in a tertiary hospital in Japan

   ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Geriatrics & gerontology international · 2020-09-13 · Biomarkers

   In older patients, typical clinical symptoms and blood test changes were often absent; however, CT always contained typical findings of COVID-19, suggesting that CT may be a useful diagnostic tool.

   • Care Services
5. 44/100

   The characteristics of camptocormia in patients with Parkinson's disease: A large cross-sectional multicenter study in Japan

   ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the neurological sciences · 2015-09-08 · Biomarkers

   The goal of the present study was to clarify the clinical characteristics and laboratory results of parkinsonian symptoms among patients with and without camptocormia.

   • Brain Scans
   • Other Dementias
6. 62/100

   Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan

   ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Annals of neurology · 1998-07-01 · Tau biomarkers

   To clarify the alterations of tau, amyloid beta protein (A beta) 1-40 and A beta1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with non-AD dementia, 56 with other neurological diseases, and 54 normal control subjects from three independent institutes were analyzed by sensitive enzyme-linked immunosorbent assays.

   • Biomarkers

All topic tags with their study counts